Abstract
Frontiers Events is a rapidly growing calendar management system dedicated to the scheduling of academic events. This includes announcements and invitations, participant listings and search functionality, abstract handling and publication, related events and post-event exchanges. Whether an organizer or participant, make your event a Frontiers Event!
Highlights
Developing a vaccine against hepatitis C virus (HCV) infection is an important medical priority
We have previously shown that adenovirus-vaccine encoding non-structural (NS) hepatitis C virus (HCV) proteins induces potent T-cell responses and efficacy studies in chimpanzees demonstrate that these responses can be protective against challenge
Our phase I trial based on prime/boost with a simian Adenoviral (ChAd3) and MVA expressing the HCV-NS antigen has demonstrated that this vaccine strategy is safe and highly immunogenic
Summary
Developing a vaccine against hepatitis C virus (HCV) infection is an important medical priority. Induction of robust T cell responses could provide effective immune control.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
